Clinical trial

PET in Breast Cancer Receiving Neoadjuvant Chemotherapy

NCT01396655

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-07-01

PhasePHASE2

Study timeline

Study start (unknown)2006-07-01Date precision: month

Registry last updated2025-04-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

docetaxel (75 mg/m2) and doxorubicin (50 mg/m2)DRUG

Sponsors & collaborators

Seoul National University Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01396655 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.